Foresight Diagnostics company information, Employees & Contact Information

Foresight Diagnostics and Roche Enter Licensing Agreement for PhasED-Seq™ Technology in Non-Hodgkin's Lymphoma PR Newswire

Foresight Diagnostics Provides 2025 Outlook and 2024 Year in Review GlobeNewswire

Foresight Diagnostics to Present Clinical Performance Data on Foresight CLARITY™ MRD at IASLC 2025 World Conference on Lung Cancer PR Newswire

New ultra-sensitive DNA blood test for detecting residual cancer in B-cell lymphoma patients EurekAlert!

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships Business Wire

Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma The Malaysian Reserve

Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma Allogene

Foresight Diagnostics Expands Series B Financing to $73.75 Million to Advance the Foresight CLARITY™ MRD Platform Yahoo Finance

NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma GlobeNewswire

Foresight Diagnostics Announces Publication of Landmark Study Demonstrating Prognostic Value of Ultrasensitive ctDNA-MRD Detection in Large B-Cell Lymphoma PR Newswire

Foresight Diagnostics Launches PRECISE-HL Trial to Explore ctDNA-Based Therapy De-Escalation in Classical Hodgkin Lymphoma (cHL) PR Newswire

Foresight Diagnostics and Partners to Present Independent Validation Data for its CLARITY™ MRD Assay at the 2025 European Hematology Association (EHA) Congress and International Conference on Malignant Lymphoma (ICML) PR Newswire

Foresight Diagnostics and Partners to Present New Data on Ultra-sensitive Minimal Residual Disease Detection and Clinical Trial Progress at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire

Foresight Diagnostics Expands Strategic Partnership with Allogene Therapeutics to Advance Joint Development Activities Outside of the U.S. Across Europe, UK, Canada and Australia PR Newswire

Foresight Diagnostics announces $58.75 Million Series B financing led by Foresite Capital to commercialize ultrasensitive liquid biopsy MRD testing platform PR Newswire

Foresight Diagnostics Presents Independent Validation of its CLARITY Minimal Residual Disease (MRD) Assay in Multicenter Study of Frontline DLBCL at the 2025 ASCO Annual Meeting PR Newswire

Foresight Diagnostics to Present New Data Showcasing Foresight CLARITY MRD Detection in Early-Stage Lung Cancer PR Newswire

Roche levels trade secrets lawsuit against Stanford University and its cancer detection spinout Foresight Diagnostics Fierce Biotech

Danaher Discusses Diagnostics Biz at ADLM With Refocus on Partnerships in Key Disease Areas 360Dx

The Impact of Assuming Perfect Foresight When Planning Infrastructure in the Water–Energy–Food Nexus Frontiers

Freeway Honored With His Own Day In Philadelphia: 'A Remarkable Highlight In My Journey' HipHopDX

Snoop Dogg ‘Dimmed His Light’ To Let 2Pac Shine, Says Director Allen Hughes HipHopDX

2Pac Was ‘Delusional’ & ‘Playing A Role’ Says ‘Menace II Society’ Director Allen Hughes HipHopDX

Too $hort Doesn’t See The Value In The Older Generation Hating On Young Rappers HipHopDX